We’re hugely grateful for the core Independent Research Organisation (IRO) funding just awarded by the @HRCNewZealand. Ka tuku oha hoki ki a @TeAtawhaioTeAo, #WhakauaeResearch, and the @Malaghan_Inst who also received HRC IRO support in this funding round.
A new anti-viral, Paxlovid, has been added to the @PANORAMICTrial in the UK. 1000s more people in England are now eligible to receive the UK’s second oral antiviral treatment for COVID-19.
We’re so excited to see the growth in this study!
More here -> https://t.co/Dq8f88N3un
Interested to learn more about Mega-ROX? Chief Investigator @DogICUma explains it all in this 13 minute video https://t.co/z5GGY3W2Bx #MegaROX#LOGICALtrial
The most recent study to add to our manifest, PANORAMIC is one of the most ambitious undertaken in UK primary care.
We're excited to be involved in this trial and will be adding all the updates and information to our brand new hub page -> https://t.co/fkg1Zt1e5E
#panoramictrial
The @ascot_trial is making waves in the medical world!
Our new hub page on this trial will get you up to speed on its design, background and key connections involved in the study.
Get to know them all here -> https://t.co/Ekjdof5y5b
#clinicaltrial#spiralsoftware
Exciting news! Spiral’s platform @remap_cap was used in a trial that showed that in noncritically ill Covid-19 patients, an initial strategy of therapeutic-dose anticoagulation with heparin increased the chance of survival! More here: https://t.co/6PMtDwAqHq
#clinicaltrial
Reality show idea: a group of 20 anti-maskers living in a big house. They're told that one of them secretly has Covid (they don't). No one can leave. Watch them realise one by one how stupid they are being.
@toggltrack Definitely a fan of the product, definitely NOT a fan of the new colour scheme. Hopefully there will be some config options in the near future.